BONESUPPORT Enrolls First Patient in FORTIFY Trial With CERAMENT G
BONESUPPORT enrolled the first patient in the pivotal IDE trial of CERAMENT G in the surgical repair of open diaphyseal tibial fractures. May 22, 2017
Vericel Signs Distribution Agreement with Orsini Pharmaceutical
Vericel entered into a 2-year renewable agreement with Orsini Pharmaceutical for distribution of Carticel® and MACI® in the U.S. and Puerto Rico. May 22, 2017
Zimmer Biomet Licenses IP from Bonutti Research
Zimmer Biomet entered into an agreement to license patents from Bonutti Research, supporting the development of the Rosa® robotic total knee application. May 18, 2017
Amend Surgical Receives Funding from Florida State
Amend Surgical entered into a funding agreement in support of products for the bone graft substitute market. May 18, 2017
Stryker to Distribute AlloSource Products for Sports Medicine Procedures
Stryker entered into an agreement to distribute AlloSource biologic products in the U.S. for use in sports medicine procedures. May 18, 2017
Rotation Medical BioInductive Implant REBUILD Study Results
Interim study results indicate that patients receiving Rotation Medical’s Bioinductive Implant to treat rotator cuff disease reported statistically significant improvement at six months. May 18, 2017
Globus Medical to File Revised 510(k) for ExcelsiusGPS
Globus Medical plans to resubmit its 510(k) for the ExcelsiusGPSâ„¢ system to FDA, and noted that its clearance is now expected after 2Q17. May 18, 2017
Life Spine Announces Approval of Spine Outcomes Study
Life Spine announces the approval of a study to help determine optimal outcomes for Open vs. Minimally Invasive Posterior Lumbar Spine Surgery. May 17, 2017
Life Spine Fully Launches PROLIFT Lordotic Expandable Interbody System
Life Spine commenced full commercial launch of the PROLIFT® Lordotic expandable interbody system with OSSEO-LOC™ surface treatment. May 17, 2017
Seikagaku Enters Collaboration on SI-613 in Japan
Seikagaku entered into a basic co-development and marketing collaboration with Ono Pharmaceutical in Japan for SI-613 for the treatment of osteoarthritis. May 17, 2017
